1-Ethyl-3-methylimidazolium dicyanamide

We are 1-Ethyl-3-methylimidazolium dicyanamide CAS:370865-89-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


English Name: 1-Ethyl-3-methylimidazolium dicyanamide
Synonyms:1-Ethyl-3-methylimidazolium dicyanamide
Molecular Formula: C8H11N5
Molecular Weight: 177.21
CAS No.: 370865-89-7
Purity: 99%
 
Technical Information

Appearance:	Purity:
NMR: Passed	null
Solubility:	Insolubility:
Impurity content: （1）Methylimidazole content: < 1000 ppm; (2) Halogen content: < 1000 ppm; (3) water content: < 1000 ppm

 
Physics-Chemistry Properties

·  ·  Melting point: -21℃	Decomposition temperature: 104℃
Conductivity: 27mS/cm	Electrochemical window: 3.3V
Viscosity: 21cp	Density: 1.11 g/cm3

 
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts



Related News: The death toll in China rose to at least 304.Tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate The death toll in China rose to at least 304.adenosine CAS:58-61-7 The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.(S) -4-cloro-3-hidroxibutironitrilo CAS:127913-44-4 China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.